164 related articles for article (PubMed ID: 37137949)
1. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of lymphocyte/C-reactive protein ratio on postoperative outcomes in patients with rectal cancer who underwent curative resection.
Yamamoto T; Fukuda M; Okuchi Y; Oshimo Y; Nishikawa Y; Hisano K; Kawai T; Iguchi K; Okuda Y; Kamimura R; Tanaka E; Terajima H
Sci Rep; 2022 Oct; 12(1):17136. PubMed ID: 36229569
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
Eren T
ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
[TBL] [Abstract][Full Text] [Related]
5. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
[TBL] [Abstract][Full Text] [Related]
10. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
[TBL] [Abstract][Full Text] [Related]
11. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study.
Chen X; Guo W; Diao Z; Huang H; Liu W
Front Immunol; 2023; 14():1101222. PubMed ID: 36936907
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
Ou W; Zhou C; Zhu X; Lin L; Xu Q
Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
Cheng CB; Zhang QX; Zhuang LP; Sun JW
Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte C-reactive protein ratio: A new biomarker to predict early complications after gastrointestinal oncologic surgery.
Yildirim M; Koca B
Cancer Biomark; 2021; 31(4):409-417. PubMed ID: 34151845
[TBL] [Abstract][Full Text] [Related]
19. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?
Angin YS; Yildirim M; Dasiran F; Okan I
ANZ J Surg; 2021 Jul; 91(7-8):1521-1527. PubMed ID: 33956378
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
